Revvity (NYSE:RVTY) Price Target Raised to $165.00

Revvity (NYSE:RVTY – Get Free Report) had its price target hoisted by research analysts at JPMorgan Chase & Co. from $160.00 to $165.00 in a report released on Monday, Benzinga reports. The firm currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s target price indicates a potential upside of 10.37% from the company’s current price.

A number of other equities research analysts have also weighed in on the company. TD Cowen boosted their price target on Revvity from $175.00 to $185.00 and gave the stock a “buy” rating in a research note on Wednesday, November 4th. Evercore reaffirmed an “outperform” rating on shares of Revvity in a research report on Wednesday, August 5th. Barclays lifted their target price on shares of Revvity from $160.00 to $175.00 and gave the stock an “equal weight” rating in a research note on Wednesday, November 4th. Wall Street Zen raised shares of Revvity from a “hold” rating to a “buy” rating in a research report on Saturday. Finally, KeyCorp reissued an “overweight” rating on shares of Revvity in a research report on Monday. Six equities research analysts have rated the stock with a Buy rating and thirteen have issued a Hold rating to the company. According to MarketBeat.com, Revvity currently has an average rating of “Hold” and a consensus target price of $134.21.

View Our Latest Report on RVTY

Revvity Stock Down 3.2%

RVTY stock traded down $4.89 on Monday, hitting $149.50. 564,370 shares of the company’s stock were exchanged, compared to its average volume of 1,537,487. Revvity has a 12-month low of $81.22 and a 12-month high of $171.74. The firm has a 50 day moving average price of $150.48 and a two-hundred day moving average price of $114.30. The company has a debt-to-equity ratio of 0.36, a quick ratio of 2.10 and a current ratio of 2.65. The stock has a market cap of $16.69 billion, a P/E ratio of 66.31, a price-to-earnings-growth ratio of 2.70 and a beta of 1.08.

Revvity (NYSE:RVTY – Get Free Report) last announced its earnings results on Tuesday, November 3rd. The company reported $1.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.30 by $0.08. Revvity had a return on equity of 8.64% and a net margin of 8.61%. The company had revenue of $728.90 million for the quarter, compared to analyst estimates of $694.73 million. During the same period in the prior year, the company posted $1.18 EPS. The firm’s quarterly revenue was up 4.3% compared to the same quarter last year. As a group, equities research analysts expect that Revvity will post 5.42 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, insider Maxwell Krakowiak sold 1,631 shares of the firm’s stock in a transaction on Monday, September 21st. The shares were sold at an average price of $144.53, for a total transaction of $235,728.43. Following the completion of the transaction, the insider owned 14,781 shares of the company’s stock, valued at $2,136,297.93. This trade represents a 9.94% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Tajinder Vohra sold 7,330 shares of the business’s stock in a transaction on Wednesday, September 16th. The shares were sold at an average price of $140.88, for a total transaction of $1,032,650.40. Following the transaction, the insider owned 6,635 shares of the company’s stock, valued at $934,738.80. This represents a 52.49% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 9,045 shares of company stock worth $1,281,439 in the last quarter. Company insiders own 0.85% of the company’s stock.

Hedge Funds Weigh In On Revvity

Several large investors have recently made changes to their positions in the company. EdgePoint Investment Group Inc. boosted its stake in shares of Revvity by 3.1% in the first quarter. EdgePoint Investment Group Inc. now owns 8,800,863 shares of the company’s stock worth $771,044,000 after acquiring an additional 265,204 shares during the last quarter. Jupiter Topco LLC acquired a new position in Revvity in the 2nd quarter valued at about $961,017,000. Janus Henderson Group PLC raised its position in shares of Revvity by 2.3% during the 1st quarter. Janus Henderson Group PLC now owns 8,348,127 shares of the company’s stock valued at $731,386,000 after buying an additional 186,956 shares during the period. BlackRock Inc. acquired a new position in Revvity in the second quarter valued at approximately $852,070,000. Finally, State Street Corp grew its position in Revvity by 0.6% in the third quarter. State Street Corp now owns 4,370,897 shares of the company’s stock worth $668,266,000 after acquiring an additional 28,158 shares during the period. 86.65% of the stock is currently owned by institutional investors and hedge funds.

About Revvity

(Get Free Report)

Revvity, Inc. develops and supplies products and services for life sciences research and clinical diagnostics. Its offerings include instruments, reagents, software and related services used by pharmaceutical and biotechnology companies, academic and government research institutions, hospitals and clinical laboratories. The company’s work spans areas such as drug discovery and development, genetic testing, newborn screening and other diagnostic applications. Its technologies help researchers and healthcare providers analyze biological samples and generate information used in research and patient care.

Recommended Stories

Analyst Recommendations for Revvity (NYSE:RVTY)

Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.